MediXall Group Reports Skyrocketed Conversion Rates for Health Karma Social Media Campaigns
Back to Newsroom
Mentioned in this Article

MediXall Group Reports Skyrocketed Conversion Rates for Health Karma Social Media Campaigns

Wednesday, April 14, 2021 10:15 AM
Share this article now
Company Update

Conversion rates more than double industry standards.

FORT LAUDERDALE, FL / ACCESSWIRE / April 14, 2021 / MediXall Group, Inc. (OTCQB:MDXL), an innovative healthcare solutions provider, was pleased to announce today that the Health Karma direct-to-consumer social media campaigns are consistently reporting over 20% conversion rates.

Health Karma launched campaigns in Facebook and Google in early February as part of its direct-to-consumer marketing strategy. The average conversion rate for Facebook ads across all industries is 9.21% with healthcare reporting 11%. For the past two weeks the Health Karma Facebook campaign has yielded conversion rates of 27.06% and 23.30% respectively. Likewise, the Health Karma Google campaign has also posted successful metrics with a 31.14% conversion rate.

The company attributes the success of the marketing campaigns to the demand for affordable healthcare solutions in the market, the strength of the Health Karma product offering in delivering and simplifying the healthcare experience, and key guidance from its board of advisors on understanding consumer healthcare behavior.

The company's board of advisors is made up of healthcare professionals with decades of experience across multiple sectors including healthcare delivery, health insurance, pharma, and clinical to name a few. Advisor Ellis A. Ellis stated "Healthcare is complicated. Players have made it so convoluted and difficult to understand. We have taken our eye off the end user while costs continue to soar. When I first heard about MediXall I saw it as a company that was reimagining how we are going to deliver healthcare. With the addition of Health Karma and virtual primary care it provides the market with a solution to simplify the healthcare experience and stretch the healthcare dollar. It puts the focus back on the end user where it belongs." Mr. Ellis's background spans from clinical to healthcare policy work with a concentration on medicinal side effects. He has spent his career focused on consumer healthcare advocacy.

About MediXall Group, Inc.

MediXall Group, Inc. (OTCQB:MDXL) is a technology and innovation-driven organization purposefully designed and structured around delivering products and services to make it easier for consumers to learn, decide and pay for healthcare. The mission of MediXall Group is to revolutionize the healthcare industry by improving communication; providing better technology and support services; and enabling more efficient, cost-effective healthcare for the consumer. By approaching the entire healthcare ecosystem, MediXall creates, invests and incubates companies that embody its mission statement. For more information, please visit or call 954-908-3481.

About Health Karma, Inc.

Health Karma, a wholly owned subsidiary of MediXall Group, is a data-driven healthcare technology company that is on a mission to continually raise the bar of the healthcare experience by empowering people to understand and manage their entire health care journey anywhere, anytime, whether they have insurance or not. For more information, please visit

Safe Harbor Statement

This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. These forward-looking statements are based on current plans and expectations of management and are subject to a number of uncertainties and risks that could significantly affect the company's current plans and expectations, as well as future results of operations and financial condition. Specifically, the company's ability to raise additional capital, execute its business plan and strategy, sustain or increase gross margins, achieve profitability and build shareholder value are forward-looking statements. A more extensive listing of risks and factors that may affect the company's business prospects and cause actual results to differ materially from those described in the forward-looking statements can be found in the reports and other documents filed by the company with the Securities and Exchange Commission. The company undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.


Investor Relations
(954) 908-3481

SOURCE: MediXall Group, Inc.

MediXall Group, Inc.
Back to Newsroom


Copyright 2021 © ACCESSWIRE. All rights reserved. Privacy Policy  |   Terms and Conditions